Preclinical Assessment of a Novel Polymer-Free Hybrid Drug Eluting Stent.

J Cardiovasc Transl Res · 2025 · PMC12630216 · PMID 40815367

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

showed a trendp = 0.06so close (0.05 < p ≤ 0.1)

At 90 days, CC-EEPFS showed a trend towards lower late lumen loss compared to SS-SEPBS (see supplementary Table 7 , p = 0.06).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.